L-R: President and Managing Director, Hisamitsu UK Ltd, Mr. Hiroki Nunotani; Co-Founder and Chief Executive Officer, DrugStoc, Dr. Chibuzo Opara; President, Pharmaceutical Society of Nigeria (PSN), Prof. Cyril Usifoh; CEO, Pharmaplus and immediate past President of PSN, Pharm. Ahmed Yakassai; Executive officer, Head of International Division, Hisamitsu Pharmaceutical Co., Inc, Mr. Taro Hiramatsu; Co-Founder & President, DrugStoc, Mr. Adham Yehia; and Sales and Marketing Manager, Hisamitsu UK Ltd, Mr. Hiroshi Tsuchida, during the unveiling ceremony of Salonpas in Nigeria.

By Oluwafunke Ishola A global healthcare company, Hisamitsu Pharmaceutical Co. Inc., has introduced Salonpas, an innovative solution for pain management to Nigerians. Mr Taro Hiramatsu, Executive Officer of the company made the disclosure in a statement on Monday in Lagos. Hiramatsu said Salonpas would make a positive difference in theContinue Reading

Shell logo

By Emmanuella Anokam The Nigerian Upstream Petroleum Regulatory Commission (NUPRC) says the Shell Petroleum Development Company of Nigeria Limited (SPDC) assets being considered for divestments have an estimated reserve of 4.96 billion barrels of oil. The Commission Chief Executive of NUPRC, Mr Gbenga Komolafe disclosed this on Monday in AbujaContinue Reading